Jpmorgan Chase & CO Beyond Air, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Beyond Air, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 8,328 shares of XAIR stock, worth $3,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,328
Previous 7,833
6.32%
Holding current value
$3,081
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XAIR
# of Institutions
50Shares Held
15MCall Options Held
31.6KPut Options Held
3.4K-
Lasry Marc New York, NY4.95MShares$1.83 Million5.06% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.6MShares$1.33 Million0.57% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.48MShares$546,3510.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$467,8700.0% of portfolio
-
Bleichroeder LP New York, NY738KShares$273,1750.1% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $11.1M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...